Determination of the functionality of common APOA5 polymorphisms (Q40412696)

20 September 2017

Determination of the functionality of common APOA5 polymorphisms (English)

1 reference

20 September 2017

1

1 reference

20 September 2017

4

1 reference

20 September 2017

Jutta Palmen

2

1 reference

20 September 2017

Wendy Putt

series ordinal

3

1 reference

20 September 2017

Steve E Humphries

series ordinal

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

7 June 2005

1 reference

Journal of Biological Chemistry

20 September 2017

1 reference

20 September 2017

280

1 reference

20 September 2017

28215-28220

1 reference

20 September 2017

31

1 reference

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

20 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Structure and interfacial properties of human apolipoprotein A-V

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Primer extension analysis of eukaryotic ribosome-mRNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Tilted peptides: a motif for membrane destabilization (hypothesis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Signal sequences. The limits of variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Variation in the human ApoB signal peptide modulates ApoB17 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Downstream secondary structure facilitates recognition of initiator codons by eukaryotic ribosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Point mutation in a 3' flanking sequence of the alpha-1-antitrypsin gene associated with chronic respiratory disease occurs in a regulatory sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M502144200

21 January 2018

Identifiers

DOI

10.1074/JBC.M502144200

1 reference

20 September 2017

1 reference